Aspire Biopharma (NASDAQ:ASBP) vs. Patrick Industries (NASDAQ:PATK) Head-To-Head Comparison

Aspire Biopharma (NASDAQ:ASBP – Get Free Report) and Patrick Industries (NASDAQ:PATK – Get Free Report) are both consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Profitability

This table compares Aspire Biopharma and Patrick Industries’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Aspire Biopharma -11,362.21% N/A -177.59%
Patrick Industries 3.74% 12.69% 4.69%

Volatility and Risk

Aspire Biopharma has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Patrick Industries has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Insider and Institutional Ownership

19.2% of Aspire Biopharma shares are owned by institutional investors. Comparatively, 93.3% of Patrick Industries shares are owned by institutional investors. 5.8% of Aspire Biopharma shares are owned by insiders. Comparatively, 3.8% of Patrick Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Aspire Biopharma and Patrick Industries”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aspire Biopharma $10,000.00 1,162.00 -$24.48 million ($69.62) -0.12
Patrick Industries $3.95 billion 0.53 $135.06 million $4.22 15.42

Patrick Industries has higher revenue and earnings than Aspire Biopharma. Aspire Biopharma is trading at a lower price-to-earnings ratio than Patrick Industries, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Aspire Biopharma and Patrick Industries, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aspire Biopharma 1 0 0 0 1.00
Patrick Industries 1 2 7 0 2.60

Patrick Industries has a consensus price target of $112.33, indicating a potential upside of 72.63%. Given Patrick Industries’ stronger consensus rating and higher probable upside, analysts clearly believe Patrick Industries is more favorable than Aspire Biopharma.

Summary

Patrick Industries beats Aspire Biopharma on 12 of the 14 factors compared between the two stocks.

About Aspire Biopharma

(Get Free Report)

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.

About Patrick Industries

(Get Free Report)

Patrick Industries, Inc. manufactures and distributes component products and materials for the recreational vehicle, marine, manufactured housing, and industrial markets in the United States, Mexico, China, and Canada. Its Manufacturing segment manufactures and sells laminated products for furniture, shelving, wall, countertop, and cabinet products; cabinet doors, fiberglass bath fixtures, and tile systems; hardwood furniture, vinyl printing, amplifiers, tower speakers, soundbars, and subwoofers; solid surface, granite, and quartz countertop fabrication; aluminum products; fiberglass and plastic components; RV paintings; decorative vinyl and paper laminated panels; softwoods lumber; custom cabinets; polymer-based flooring products; dash panels; and other products. This segment also provides wrapped vinyl, paper, and hardwood profile mouldings; interior passage doors; air handling products; slide-out trim and fascia; treated, untreated, and laminated plywood; fiberglass and plastic helm systems and components; boat towers, tops, trailers, and frames; adhesives and sealants; thermoformed shower surrounds; specialty bath, and closet building products; wiring and wire harnesses; aluminum and plastic fuel tanks; CNC molds, composite parts, marine hardware; slotwall panels, components; and other products. The company's Distribution segment distributes pre-finished wall and ceiling panels, drywall and finishing products, electronic and audio system components, appliances, marine accessories, wiring products, electrical and plumbing products, fiber reinforced polyester products; cement siding products, raw and processed lumber, interior passage, roofing, laminate, and ceramic flooring products, shower doors, furniture, fireplaces and surrounds, interior and exterior lighting products, and other products. This segment also offers transportation and logistics services. Patrick Industries, Inc. was incorporated in 1959 and is based in Elkhart, Indiana.

Receive News & Ratings for Aspire Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspire Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.